Literature DB >> 10462629

Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples.

H Rinder1, K Feldmann, E Tortoli, J Grosset, M Casal, E Richter, M Rifai, V Jarlier, M Vaquero, S Rüsch-Gerdes, E Cambau, J Gutierrez, T Löscher.   

Abstract

BACKGROUND: The molecular prediction of isoniazid (INH) resistance in Mycobacterium tuberculosis is hampered by the need for specialized equipment, expertise, high costs, a limited range of detectable mutations, or several of these factors. The rationale for the study was to find a practical alternative and to demonstrate generally valid problems. METHODS AND
RESULTS: DNA extracted from decontaminated sputum pellets was used to amplify a 0.26 kb target sequence within the katG gene. Mutations of codon 315, frequently found in isoniazid-resistant isolates, could be discriminated in a simple agarose minigel format following an AciI digest of the nested polymerase chain reaction (PCR) product. Within a panel of 22 sputum samples, INH resistance could be predicted in 5 of 10 samples containing isoniazid-resistant M. tuberculosis. The protocol is robust, requires little expertise and no specialized equipment, and provides the test results within 2 days.
CONCLUSION: The results show the feasibility to rapidly and easily detect mutations highly predictive of isoniazid resistance. Nevertheless, this, like any other molecular resistance prediction test, is affected by often neglected factors, including mutation prevalences, the phenomenon of heteroresistance, and a possible bias toward one's own method.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462629     DOI: 10.1016/s1084-8592(99)80038-1

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  4 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania.

Authors:  Daiva Bakonyte; Aurelija Baranauskaite; Jurate Cicenaite; Anaida Sosnovskaja; Petras Stakenas
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

3.  Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

Authors:  Francesca Meacci; Germano Orrù; Elisabetta Iona; Federico Giannoni; Claudio Piersimoni; Gianni Pozzi; Lanfranco Fattorini; Marco R Oggioni
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Authors:  Linda M Parsons; Max Salfinger; Anne Clobridge; Jillian Dormandy; Lisa Mirabello; Valerie L Polletta; Ahmet Sanic; Oleg Sinyavskiy; Susan C Larsen; Jeffrey Driscoll; Genet Zickas; Harry W Taber
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.